| Price | 3.835p on 29-06-2026 at 15:40:00 |
|---|---|
| Change | 0.115p 3.09% |
| Buy | 4.195p |
| Sell | 3.795p |
| Last Trade: | Buy 78.00 at 3.835p |
| Day's Volume: | 6,673,838 |
| Last Close: | 3.835p |
| Open: | 3.975p |
| ISIN: | GB0033711010 |
| Day's Range | 3.60p - 4.40p |
| 52wk Range: | 1.40p - 19.00p |
| Market Capitalisation: | £23.93m |
| VWAP: | 3.956844p |
| Shares in Issue: | 623.91m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Immupharma (IMM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 78 | 3.835p | Suspected BUY Trade |
16:35:02 - 29-Jun-26 |
| Sell* | 129 | 3.805p | Ordinary |
16:24:09 - 29-Jun-26 |
| Sell* | 19,794 | 3.8092p | Ordinary |
16:23:27 - 29-Jun-26 |
| Sell* | 13,755 | 3.948p | Ordinary |
16:10:48 - 29-Jun-26 |
| Sell* | 15,096 | 3.948p | Ordinary |
16:09:34 - 29-Jun-26 |
| Buy* | 30,000 | 3.86p | Automatic Execution |
16:08:04 - 29-Jun-26 |
| Buy* | 45,509 | 3.8367p | Ordinary |
16:07:27 - 29-Jun-26 |
| Sell* | 75,000 | 3.80p | Automatic Execution |
15:59:47 - 29-Jun-26 |
| Sell* | 50,000 | 3.80p | Automatic Execution |
15:59:47 - 29-Jun-26 |
| Sell* | 55,000 | 3.824p | Ordinary |
15:59:41 - 29-Jun-26 |
Immupharma (IMM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 25th Jun 2026 1:20 pm | RNS | 2026 RESULT OF ANNUAL GENERAL MEETING |
| 25th Jun 2026 7:00 am | RNS | ImmuPharma appoints Bachem for Kapiglucagon API |
| 24th Jun 2026 7:00 am | RNS-R | University of Murcia research relating to P140 |
| 4th Jun 2026 7:10 am | RNS-R | Incanthera plc – Corporate Update & Board Changes |
| 2nd Jun 2026 7:00 am | RNS | Notice of AGM & Annual Report & Accounts |
| 27th May 2026 7:00 am | RNS | Final Results |
| 5th May 2026 7:00 am | RNS | IMM initiatesIND-Enabling Program for Kapiglucagon |
| 10th Apr 2026 7:00 am | RNS | Holding(s) in Company |
| 9th Apr 2026 7:00 am | RNS-R | Chairman’s Open Letter to Shareholders |
| 7th Apr 2026 11:45 am | RNS | Result of General Meeting and TVR |
